Skip to main content

1 Result(s)

within Dirkje W Sommeijer Remove this filter Cancer Research Remove this filter

and

  1. Article

    Open Access

    Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone

    Patient selection for addition of anti-EGFR therapy to chemotherapy for patients with RAS and BRAF wildtype metastatic colorectal cancer can still be optimised. Here we investigate the effect of anti-EGFR therapy...

    Sanne ten Hoorn, Dirkje W. Sommeijer, Faye Elliott… in British Journal of Cancer (2021)

    Download PDF (587 KB) View Article